We use third-party cookies in order to personalize your site experience. See our Privacy Policy.

LEARN

Technology intelligence for public-equity investors

See the technology shifts moving your holdings — before the market reprices them.

CanaryIQ Research Updated June 2026

In public markets, the technology story behind a company often moves the stock long before it shows up in the financials. Technology intelligence gives investors an evidence-based read on those shifts while there is still time to act.

Anticipate disruption

The forces that disrupt an incumbent — a new approach maturing in research, a wave of patents, capital concentrating around a challenger — are visible early if you are watching the right signals. Technology intelligence turns that into a monitored, structured view rather than a hunch.

Separate durable shifts from hype

Markets overreact to narratives in both directions. Weighing attention against the underlying evidence helps investors avoid chasing hype and avoid dismissing a shift that is quietly becoming real.

Keep exploring

Common questions

Public-market investors use technology intelligence to understand the technology forces acting on the companies they hold or are considering — monitoring research momentum, patent activity, and adoption signals that tend to show up in the evidence well before they appear in earnings. It helps analysts build a more structured, evidence-based view of which technology narratives are real and which are still speculative.

No — it complements it. Fundamental research remains essential for evaluating financial health, management quality, and valuation. Technology intelligence adds a layer that fundamental research typically does not cover: a structured read on whether the technology claims a company makes — or the disruption risk it faces — are grounded in evidence. The two approaches reinforce each other.

Technology signals — research publications, patent filings, early capital flows into a space — typically lead the market by a meaningful margin, often years. The lead time varies by domain and how quickly a technology moves from research into commercial products, but in most cases the evidence base precedes the point at which a shift becomes consensus. That gap is where the value of monitoring lies.

Built for public-market investors